Clinical trial Recruiting at 1 site Interventional Ages 18 to 70 Women only

Effectiveness of M-TAPA nerve block for pain relief after laparoscopic hysterectomy

Official title: Effectiveness of Modified-Thoracoabdominal Nerve Block With Perichondrial Approach (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy Surgery: A Prospective, Randomized, Double-Blind, Controlled Study

Run by Istinye University · NCT07483190 · Data updated 2026-11-12

This study tests whether the M-TAPA nerve block before surgery can reduce opioid use and pain after laparoscopic hysterectomy compared with standard pain care.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment60 (estimated)
SponsorIstinye University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedJune 9, 2026
Main results expectedOctober 15, 2026
Study endsNovember 15, 2026
Registry record updatedJune 16, 2026
Trial IDNCT07483190 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 years scheduled for elective laparoscopic hysterectomy with ASA I–III, eligible for regional anesthesia, and who consent to participate.

Probably not a fit

Patients with contraindications to regional anesthesia, BMIs above 35, or those who do not respond to the block may not see a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study assigns adults undergoing elective laparoscopic hysterectomy to receive either the Modified-Thoracoabdominal Nerve Block through a Perichondrial Approach (M-TAPA) with bupivacaine before surgery or standard postoperative pain management without the block. The main outcome is total morphine consumption in the first 24 hours after surgery, with secondary outcomes including pain scores, time to first analgesic request, patient satisfaction, and side effects such as nausea. Participants are adults 18 to 70 years old with ASA I–III, without significant hepatic/renal disease, coagulation disorders, or allergies to local anesthetics, and who consent to regional anesthesia. The trial is conducted at Istinye University Liv Hospital Bahcesehir in Istanbul, sponsored by Istinye University.

Why it matters

Potential benefit: If successful, patients may experience less opioid use and better pain control after surgery, potentially speeding recovery.

How similar studies have gone: Prior regional anesthesia approaches have shown pain reductions in similar abdominal surgeries, though this specific M-TAPA approach is being tested for this procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 70 years
* ASA (American Society of Anesthesiologists) physical status I, II, or III
* Scheduled for elective laparoscopic hysterectomy
* Voluntary participation with signed informed consent

Exclusion Criteria:

* Hepatic or renal disease.
* Coagulation disorders.
* Uncontrolled cardiovascular or respiratory diseases.
* Psychiatric disorders.
* History of allergy to local anesthetics.
* History of alcoholism, drug or substance abuse.
* Body Mass Index (BMI) greater than 35 kg/m2
* Refusal of the regional block procedure

Where it's running

  • Istinye University Liv Hospital Bahcesehir
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.